Geron Announces Presentations at American Society of Hematology Annual Meeting
November 03, 2016 09:12 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that four abstracts related to the imetelstat program have been accepted for presentation at...
Geron Announces Conference Call to Discuss Third Quarter 2016 Financial Results
October 26, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the third quarter ended September 30, 2016, on Thursday, November 3,...
Geron Provides Update on Imetelstat Trials Being Conducted by Janssen
September 12, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today provided updates on the clinical trials being conducted by Janssen Research & Development, LLC, of...
Geron Announces Conference Call on September 12 at 8:00 A.M. Eastern Time
September 11, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Sept. 11, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will host a conference call on September 12, 2016, at 8:00 a.m. Eastern Time to provide an update on the...
Geron Corporation Reports Second Quarter 2016 Financial Results and Recent Events
August 03, 2016 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and six months ended June 30, 2016 and recent events. For the...
Geron Announces Conference Call to Discuss Second Quarter 2016 Financial Results
July 27, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the second quarter ended June 30, 2016, on Wednesday, August 3, 2016,...
Geron Announces Issuance of U.S. Patents Related to Imetelstat
July 13, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., July 13, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the recent issuance of three U.S. patents related to the company’s telomerase inhibitor,...
Geron Corporation Reports First Quarter 2016 Financial Results and Recent Events
May 05, 2016 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2016 and recent events.First Quarter 2016...
Geron Announces Conference Call to Discuss First Quarter 2016 Financial Results
April 27, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the first quarter ended March 31, 2016, on Thursday, May 5, 2016,...
Geron Announces Two Imetelstat Poster Presentations at the American Association for Cancer Research Annual Meeting
April 20, 2016 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced two poster presentations of data from non-clinical studies of the telomerase inhibitor,...